BARKLEY PSYCHIATRIC-MENTAL HEALTH
NURSE PRACTITIONER (PMHNP)
DIAGNOSTIC READINESS TEST (DRT) |
COMPLETE PRACTICE EXAM WITH
VERIFIED QUESTIONS AND CORRECT
ANSWERS PLUS RATIONALES 2026 Q&A |
INSTANT DOWNLOAD PDF
CORE DOMAINS
• Scientific Foundation (pathophysiology, pharmacology,
psychopharmacology, neurodevelopment, neuroanatomy,
neurophysiology, psychogenomics)
• Advanced Practice Skills (assessment, diagnosis, care planning,
implementation, evaluation, consultation)
• Diagnosis and Treatment (DSM-5-TR criteria, differential diagnosis,
psychopharmacotherapeutic management, evidence-based
practice)
• Psychotherapy and Related Theories (CBT, DBT, IPT, humanistic,
behavioral, change theories, developmental theories, family
theories)
• Ethics, Legal Principles, and Cultural Care (confidentiality,
informed consent, duty to warn, involuntary commitment, cultural
competence)
• Crisis Intervention and Safety Planning (suicide risk, homicide
risk, acute agitation, trauma responses)
, • Psychiatric Disorders Across the Lifespan (child/adolescent, adult,
older adult conditions)
• Complementary and Alternative Interventions (integrative
approaches, lifestyle modifications)
INTRODUCTION
This comprehensive practice examination is designed to prepare
Psychiatric-Mental Health Nurse Practitioner candidates for the Barkley
Diagnostic Readiness Test (DRT) and the ANCC PMHNP-BC certification
examination. The assessment evaluates critical knowledge areas including
psychopharmacology, DSM-5-TR diagnostic criteria, psychotherapy
modalities, ethical-legal compliance, and clinical decision-making in real-
world psychiatric scenarios. All 100 multiple-choice and scenario-based
questions mirror the structure, difficulty, and content distribution of the
actual Barkley DRT, emphasizing applied professional competence over
rote memorization. Success requires mastery of foundational theory,
regulatory standards, and evidence-based treatment planning across the
lifespan.
EXAM FORMAT OVERVIEW
Component Details
Number of
100 multiple-choice items
Questions
Time Allowed 100 minutes
Remediation
45-minute review of incorrect answers with detailed rationale
Session
,Component Details
Mastery
≥ 80% total score AND within every subject area
Threshold
Contact Hours 2.5 contact hours available (requires ≥ 70% on second attemp
Each DRT may be taken a maximum of 2 times per purchase
Retake Policy
(First Assessment and Final Assessment)
SECTION ONE: QUESTIONS 1–100
SCIENTIFIC FOUNDATION (Neurobiology, Neuroanatomy,
Pathophysiology)
Question 1
Which brain structure is primarily responsible for generating the "fight
or flight" response?
A. Hippocampus
B. Amygdala
C. Thalamus
D. Prefrontal cortex
B
RATIONALE: The amygdala triggers the sympathetic nervous system
response characteristic of panic and fear responses. The hippocampus
modulates contextual memory of fear, the thalamus transmits sensory
input, and the prefrontal cortex regulates emotion but does not generate
the panic response.
, Question 2
Hyperactivity of which dopaminergic pathway is most closely associated
with the positive symptoms of schizophrenia?
A. Mesocortical pathway
B. Nigrostriatal pathway
C. Mesolimbic pathway
D. Tuberoinfundibular pathway
C
RATIONALE: Hyperactivity of the mesolimbic dopaminergic pathway
contributes to hallucinations and delusions—the positive symptoms of
schizophrenia. The mesocortical pathway is associated with negative
and cognitive symptoms, the nigrostriatal pathway with movement, and
the tuberoinfundibular pathway with prolactin regulation.
Question 3
A patient with major depressive disorder reports diminished interest in
all activities, fatigue, and poor concentration. Which neurotransmitter
systems are most implicated in these symptoms?
A. GABA and glutamate
B. Dopamine and serotonin
C. Acetylcholine and histamine
D. Endorphins and norepinephrine
B
RATIONALE: Major depressive symptoms stem largely from
dysregulation of serotonin and dopamine pathways, which influence
mood, energy, motivation, and concentration. Norepinephrine is also
often involved but dopamine-serotonin imbalance is the foundational
pairing. GABA and glutamate primarily mediate anxiety and cognition
rather than depressive affect.
NURSE PRACTITIONER (PMHNP)
DIAGNOSTIC READINESS TEST (DRT) |
COMPLETE PRACTICE EXAM WITH
VERIFIED QUESTIONS AND CORRECT
ANSWERS PLUS RATIONALES 2026 Q&A |
INSTANT DOWNLOAD PDF
CORE DOMAINS
• Scientific Foundation (pathophysiology, pharmacology,
psychopharmacology, neurodevelopment, neuroanatomy,
neurophysiology, psychogenomics)
• Advanced Practice Skills (assessment, diagnosis, care planning,
implementation, evaluation, consultation)
• Diagnosis and Treatment (DSM-5-TR criteria, differential diagnosis,
psychopharmacotherapeutic management, evidence-based
practice)
• Psychotherapy and Related Theories (CBT, DBT, IPT, humanistic,
behavioral, change theories, developmental theories, family
theories)
• Ethics, Legal Principles, and Cultural Care (confidentiality,
informed consent, duty to warn, involuntary commitment, cultural
competence)
• Crisis Intervention and Safety Planning (suicide risk, homicide
risk, acute agitation, trauma responses)
, • Psychiatric Disorders Across the Lifespan (child/adolescent, adult,
older adult conditions)
• Complementary and Alternative Interventions (integrative
approaches, lifestyle modifications)
INTRODUCTION
This comprehensive practice examination is designed to prepare
Psychiatric-Mental Health Nurse Practitioner candidates for the Barkley
Diagnostic Readiness Test (DRT) and the ANCC PMHNP-BC certification
examination. The assessment evaluates critical knowledge areas including
psychopharmacology, DSM-5-TR diagnostic criteria, psychotherapy
modalities, ethical-legal compliance, and clinical decision-making in real-
world psychiatric scenarios. All 100 multiple-choice and scenario-based
questions mirror the structure, difficulty, and content distribution of the
actual Barkley DRT, emphasizing applied professional competence over
rote memorization. Success requires mastery of foundational theory,
regulatory standards, and evidence-based treatment planning across the
lifespan.
EXAM FORMAT OVERVIEW
Component Details
Number of
100 multiple-choice items
Questions
Time Allowed 100 minutes
Remediation
45-minute review of incorrect answers with detailed rationale
Session
,Component Details
Mastery
≥ 80% total score AND within every subject area
Threshold
Contact Hours 2.5 contact hours available (requires ≥ 70% on second attemp
Each DRT may be taken a maximum of 2 times per purchase
Retake Policy
(First Assessment and Final Assessment)
SECTION ONE: QUESTIONS 1–100
SCIENTIFIC FOUNDATION (Neurobiology, Neuroanatomy,
Pathophysiology)
Question 1
Which brain structure is primarily responsible for generating the "fight
or flight" response?
A. Hippocampus
B. Amygdala
C. Thalamus
D. Prefrontal cortex
B
RATIONALE: The amygdala triggers the sympathetic nervous system
response characteristic of panic and fear responses. The hippocampus
modulates contextual memory of fear, the thalamus transmits sensory
input, and the prefrontal cortex regulates emotion but does not generate
the panic response.
, Question 2
Hyperactivity of which dopaminergic pathway is most closely associated
with the positive symptoms of schizophrenia?
A. Mesocortical pathway
B. Nigrostriatal pathway
C. Mesolimbic pathway
D. Tuberoinfundibular pathway
C
RATIONALE: Hyperactivity of the mesolimbic dopaminergic pathway
contributes to hallucinations and delusions—the positive symptoms of
schizophrenia. The mesocortical pathway is associated with negative
and cognitive symptoms, the nigrostriatal pathway with movement, and
the tuberoinfundibular pathway with prolactin regulation.
Question 3
A patient with major depressive disorder reports diminished interest in
all activities, fatigue, and poor concentration. Which neurotransmitter
systems are most implicated in these symptoms?
A. GABA and glutamate
B. Dopamine and serotonin
C. Acetylcholine and histamine
D. Endorphins and norepinephrine
B
RATIONALE: Major depressive symptoms stem largely from
dysregulation of serotonin and dopamine pathways, which influence
mood, energy, motivation, and concentration. Norepinephrine is also
often involved but dopamine-serotonin imbalance is the foundational
pairing. GABA and glutamate primarily mediate anxiety and cognition
rather than depressive affect.
